Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Unilife Corp UNISQ

"Unilife Corp is engaged in the business of designing, manufacturing and supplying injectable drug delivery systems and wearable injectors. Its product portfolio encompasses wearable injector 2-10ml bolus, wearable injector basal-bolus insulin, auto-injector reusable system etc. The company's majority oil products are designed for sale directly to pharmaceutical and biotechnology companies. It... see more

OTCPK:UNISQ - Post Discussion

Unilife Corp > Could be a huge winner
View:
Post by equityman33 on Oct 18, 2012 10:39am

Could be a huge winner

Unilife could be making medical history- a company that has reinvented the traditional syringe and in the process made investors rich. The pacts that soon will be commenced soon, can give some proportions in the context of how big this business will be.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities